期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

糖尿病管理361°:降糖、降压、调脂、抗凝、监测 被引量：3

Comprehensive management of diabetes mellitus
下载PDF
导出
摘要 糖尿病是一组以血浆葡萄糖水平升高为特征的代谢性疾病,随着我国社会经济的飞速发展和人民生活方式的改变,糖尿病的人群迅速增长。根据国际糖尿病联盟（IDF）统计,目前全球有糖尿病患者2.85亿,
作者 巴建明 王立雪
机构地区 解放军总医院内分泌科 北京电力医院干部病房
出处 《药品评价》 CAS 2012年第1期9-16,共8页 Drug Evaluation
关键词 血糖管理 降压治疗 血脂管理 抗凝治疗
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献5

  • 1Colhon HM,Betteridge DJ,Durrington PN,et al.Primary prevention ofcardiovascular disease with atorvastain in type 2 diabetes in the CollaborativeAtorvastatin Diabetes Study(CARDS):multicentre randomised placebo-controlled tria1[J].Lancet,2004,364:685-696.
  • 2Heart Protection Study Collaborative Group.MRC/BHF Heart ProtectionStudy of cholesterol lowering with simvastatin in 20536 high-risk individuals:aran domized placebo-controlled tria1[J].Lancet,2002,360(9326):7-22.
  • 3Pyorala K,Pederson TR,Kjekshus L,et al.For the Scandinavian SimvastalinSurvival Study:cholesterol lowering with Simvastatin improves prognosisof diabetic patients with coronary heart disease:a subgroup analysis of thescandinavian Survival Study(4S)[J].Diabetes Care,1997,20:614-620.
  • 4Berl T,Hunsicker LG,Lewis JB,et al.Irbesartan Diabetic Nephropathy TrialCollaborative Study Group.Cardiovascular outcomes in the IrbesartanDiabetic Nephropathy Trial of patients with type 2 diabetes and overtnephropathy[J].Ann Intern Med,2003,138:542-549.
  • 5Chobanian AV,Bakris GL,Black HR,et al.National Heart,Lung,and BloodInstitute Joint National Committee on Prevention,Detection,Evaluation,andTreatment of High Blood Pressure,National High Blood Pressure EducationProgram Coordinating Committee.The Seventh Report of the Joint NationalCommittee on Prevention,Detection,Evaluation,and Treatment of HighBlood Pressure:the JNC 7 report[J].JAMA,2003,289:2560-2572.

同被引文献22

  • 1中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[S].中国糖尿病杂志,2012,20(1):S6.
  • 2Cascio G,Schiera G,Diliegro I,et al.Dietary fatty acids in metabolic syndrome,diabetes and cardiovascular diseases[J].Curr Diabetes Rev,2012,8(1):2-17.
  • 3Angeli F,Reboldi G,Garofoli M,et al.Very early initiation of statin therapy and mortality in patients with acute coronary syndrome[J].Acute Card,2012,14(1):34-39.
  • 4Bousser M G,Amarenco P,Chamorro A,et al.Terutroban versus aspirin in patients with cerebral ischaemic events(PERFORM):a randomised,doubleblind,parallel-group trial[J].Lancet,2011,377(9782):2013-2022.
  • 5Sheng X,Murphy MJ,Macdonald TM,et al.Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus:apopulation-based cohort study[J].Eur J Clin Pharmacol,2012,22:1303.
  • 6Riche DM,McClendon KS.Role of statins for the primary prevention of cardiovascular disease in patients with type 2diabetes mellitus[J].Am J Health Syst Pharm,2007,64:1603-1610.
  • 7Yang W,Lu J, Weng J. Prevalence of diabetes among menandwomen in China,N Engl J Med 2010;362( 12) :1090-1101.
  • 8DeFronzo RA, Abdul Ghani M. Assessmet and treatment ofcardiovascular risk in prediabetes impaired giucose tolerance and im-paired fasting glucose. Am J Cardiol 2011; 108?3 suppl) :3B-24B.
  • 9Li G,Zhang P, Wang J,et al. The long-term effect of lifestyleinterventions to prevent diabetes in the China Da Qing Diabetea pre-vention study : a 20-year follow-up study, Larcet 2008 ; 371 : 1783-1789.
  • 10Hu FB Siampter MJ,Haffner,et al. Elevated risk of cardiovas-cular disease prior to clinical diagnosis of type 2 diabetes . DiabetesCare 2002 ;25 : 1129-1134.

引证文献3

二级引证文献20

药品评价
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部